Fineline Cube

Follow:
14433 Articles
Takeda Reports 4.5% Revenue Growth in First Nine Months of Fiscal Year
Company

Takeda Reports 4.5% Revenue Growth in First Nine Months of Fiscal Year

Daiichi Sankyo Reports 16.6% Revenue Growth in First Three Quarters of FY2024
Company

Daiichi Sankyo Reports 16.6% Revenue Growth in First Three Quarters of FY2024

AstraZeneca Reports 7% Revenue Growth in 2024, Expects Steady Performance in 2025
Company

Pfizer Reports 7% Revenue Growth in 2024, Expects Steady Performance in 2025

China's MoC Lists US Firms PVH and Illumina as Unreliable Entities
CompanyDrug

China’s MoC Lists US Firms PVH and Illumina as Unreliable Entities

Roche Reports 7% Growth in Full-Year Sales, Strength in Pharmaceuticals
Company

Roche Reports 7% Growth in Full-Year Sales, Strength in Pharmaceuticals

Sanofi Reports Strong Q4 Growth, Plans EUR 5 Billion Share Buyback
Company

Sanofi Reports Strong Q4 Growth, Plans EUR 5 Billion Share Buyback

Xtalpi Partners with JW Pharmaceutical to Enhance Drug Discovery with AI
CompanyDeals

Xtalpi Partners with JW Pharmaceutical to Enhance Drug Discovery with AI

DeepSeek's AI: Transforming Drug Development and Healthcare in China
Company

DeepSeek’s AI: Transforming Drug Development and Healthcare in China

MediLink Therapeutics' YL217 Receives FDA IND Clearance for Novel ADC Targeting Gastrointestinal Cancers
CompanyDrug

MediLink Therapeutics’ YL217 Receives FDA IND Clearance for Novel ADC Targeting Gastrointestinal Cancers

AbbVie's 2024 Revenue Grows Despite Humira Decline, Skyrizi and Rinvoq Surge
Company

AbbVie’s 2024 Revenue Grows Despite Humira Decline, Skyrizi and Rinvoq Surge

PegBio's Lead Product PB-119 Clears HKEX Hearing for Type 2 Diabetes and Obesity Treatment
Company

PegBio’s Lead Product PB-119 Clears HKEX Hearing for Type 2 Diabetes and Obesity Treatment

Roche Reports 7% Revenue Growth in 2024, Driven by Oncology and Ophthalmology
Company

Roche Reports 7% Revenue Growth in 2024, Driven by Oncology and Ophthalmology